EP2108366
Ídebenón til meðhöndlunar á öndunarsjúkleika í vöðvavisnun.
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
9.4.2008EP published:
19.10.2011EP application number:
08007069.1
EP translation filed:
19.12.2011Grant published:
15.1.2012EPO information:
European Patent Register
Max expiry date:
8.4.2028Expiry date:
8.4.2022
Title:
Idebenone for the treatment of respiratory illness in muscular dystrophy
Timeline
Today
9.4.2008EP application
19.10.2011EP Publication
19.12.2011Translation submitted
15.1.2012Registration published
8.4.2022Expires
Owner
Name:
Santhera Pharmaceuticals (Schweiz) AGAddress:
Hammerstrasse 49, 4410, Liestal, CH
Inventor
Name:
Buyse, GunnarAddress:
Hevent, BE
Name:
Meier, ThomasAddress:
Basel, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Classification
Categories:
A61K 31/122, A61P 11/00, A61P 21/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 20.3.2012
Expires: 8.4.2013
Payer: Árnason Faktor
Number: 6
Paid: 25.3.2013
Expires: 8.4.2014
Payer: Árnason Faktor
Number: 7
Paid: 21.3.2014
Expires: 8.4.2015
Payer: Árnason Faktor
Number: 8
Paid: 24.3.2015
Expires: 8.4.2016
Payer: Árnason Faktor
Number: 9
Paid: 22.3.2016
Expires: 8.4.2017
Payer: Árnason Faktor
Number: 10
Paid: 27.3.2017
Expires: 8.4.2018
Payer: Árnason Faktor
Number: 11
Paid: 26.3.2018
Expires: 8.4.2019
Payer: Árnason Faktor
Number: 12
Paid: 26.3.2019
Expires: 8.4.2020
Payer: Árnason Faktor
Number: 13
Paid: 22.4.2020
Expires: 8.4.2021
Payer: Árnason Faktor ehf.
Number: 14
Paid: 22.3.2021
Expires: 8.4.2022
Payer: Árnason Faktor ehf.